Dudediligence.

C4 Therapeutics, Inc

CCCCNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 258-KRegulation FD disclosure and other events7.018.019.01
  2. Aug 1110-QQuarterly report
  3. Aug 118-KResults of operations2.029.01
  4. Jul 2713GPassive stake of 5% or more (13G), filed by BlackRock
  5. Jun 248-KShareholder vote5.079.01
  6. Jun 118-KRegulation FD disclosure and other events7.018.019.01
  7. May 158-KOfficer or director change5.02
  8. May 1210-QQuarterly report
  9. May 128-KResults of operations and Regulation FD disclosure2.027.019.01
  10. Apr 108-KBylaws or fiscal year changed5.039.01
  11. Apr 98-KMaterial agreement and Regulation FD disclosure1.017.019.01
  12. Feb 2610-KAnnual report
  13. Feb 268-KResults of operations2.029.01
  14. Jan 148-KRegulation FD disclosure7.019.01
  15. Dec 10, 2025424B5Prospectus for an offering
  16. Nov 21, 2025S-3Shelf registration
  17. Nov 6, 202510-QQuarterly report
  18. Nov 6, 20258-KResults of operations2.029.01
  19. Oct 16, 20258-KMaterial agreement1.019.01
  20. Oct 16, 2025424B5Prospectus for an offering
  21. Oct 16, 20258-KOther events8.01
  22. Oct 1, 20258-KRegulation FD disclosure and other events7.018.019.01
  23. Sep 22, 20258-KRegulation FD disclosure and other events7.018.019.01
  24. Aug 7, 202510-QQuarterly report
  25. Aug 7, 20258-KResults of operations and Regulation FD disclosure2.027.018.019.01
  26. Jun 18, 20258-KBylaws or fiscal year changed and shareholder vote5.035.079.01
  27. May 7, 202510-QQuarterly report
  28. May 7, 20258-KResults of operations and Regulation FD disclosure2.027.018.019.01
  29. Apr 14, 20258-KOfficer or director change5.02
  30. Feb 27, 202510-KAnnual report
  31. Feb 27, 20258-KResults of operations2.029.01
  32. Jan 14, 20258-KResults of operations and Regulation FD disclosure2.027.01
  33. Dec 9, 20248-KOther events8.019.01
  34. Nov 20, 20248-KOfficer or director change and Regulation FD disclosure5.027.019.01
  35. Nov 15, 2024424B3Prospectus for an offering
  36. Nov 15, 2024424B5Prospectus for an offering
  37. Oct 31, 2024S-3Shelf registration
  38. Oct 31, 2024S-3Shelf registration
  39. Oct 31, 202410-QQuarterly report
  40. Oct 31, 20248-KResults of operations2.029.01
  41. Oct 15, 20248-K/AOfficer or director change and Regulation FD disclosure (amended)5.027.019.01
  42. Oct 15, 20248-KOfficer or director change and Regulation FD disclosure5.027.019.01
  43. Oct 11, 20248-KOfficer or director change5.029.01